Ogechukwu Ndum, MD
Allergy & Immunology · Lebanon, NHNPI 1205198512
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by GSK at 39.3% of the total. Reporting peaked in 2019 at $969 and has fallen 92.9% since, to $69 in 2025.
Across 49 payments — averaging $22.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$439
- AstraZeneca$146
- Regeneron Healthcare Solutions, Inc.$102
- Shire North American Group Inc$91
- Sanofi$72
- Grifols USA, LLC$64
- plus $203 from 7 others
What the payments were for
- Food & beverage$1,118100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 17 | $439 |
| AstraZeneca | 6 | $146 |
| Regeneron Healthcare Solutions, Inc. | 5 | $102 |
| Shire North American Group Inc | 4 | $91 |
| Sanofi | 3 | $72 |
| Grifols USA, LLC | 3 | $64 |
| Biocryst US Sales Co., LLC | 2 | $57 |
| Genentech USA, Inc. | 2 | $39 |
| Pfizer | 3 | $39 |
| Kaleo, Inc. | 1 | $21 |
| Optinose US, Inc. | 1 | $19 |
| Novartis | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$117
How this compares
Too few allergy & immunology providers in New Hampshireto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 19 | $483 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Lebanon
- Anne MiranowskiLebanon$9K
- Karen Hsu BlatmanLebanon$9K
- Donald WoodmanseeLebanon$122
- Susan MozzicatoLebanon$28
- An HuynhLebanon$19
- Walter RyanNashua$8K
- Ashok ShahNewmarket$5K
- Mark WindtNorth Hampton$970
- Amitha HarishNashua$526
- Sarah Taylor BlackKeene$25
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.